Genes associated with pluripotency, or "stemness" are very important not only from a scientific research perspective, but also from the perspective of clinically developing stem cell therapeutics. Specifically, during clinical development of any biological, it is important to possess numerous quality control assays. The current patent covers a novel gene whose expression seems to be restricted only to embryonic stem cells. The actual name of the gene is not mentioned.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.